For example, the C/EBPδ promoter is silenced in about 35% of human acute myeloid leukemia samples [74], and its expression is downregulated in the blast crisis phases of chronic myelogenous leukemia (CML) [75]. The gene discussed is CEBPD; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.